All filters
Abstracts
Laboratory evaluation of Chembioâ„¢ DPP Syphilis Screen & Confirm assay
C. Ogola Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Molecular Characterization of Mycobacterium tuberculosis Complex in Cattle and Humans in Maiduguri, Borno State, Nigeria
A. Kwaghe Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Isoniazid and rifampicin resistance and patient treatment response in a tuberculosis and HIV-1 co-endemic population in Western Kenya
C. Likhovole Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Experiences of using mentor mothers to integrate ECD components into a PMTCT programme in a high-burden setting in Malawi
T. Mayani Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
A comparative analysis of adherence and completion rates in tb preventive therapy (TPT) among people living with HIV on 3-months & 6-months Multi-month ART dispensing
K. Kakanfo Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
4-in-1 granules for HIV treatment in children: LOLIPOP study interim analysis results
A. Kekitiinwa Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Prevalence of drug resistance mutations among HIV positive individuals with low level viremia on antiretroviral therapy in Botswana
O. Bareng Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Gender based violence among discordant couples in care and associated factors in accessing GBV post care; a cross sectional survey at aids information center (AIC) Uganda
N. Elizabeth Reviews in Antiviral Therapy & Infectious Diseases 10, 2020  
Presented at:
INTEREST 2020
Abstracts
Presence of HIV drug resistance in people re-initiating first-line antiretroviral therapy after treatment interruption in Namibia
E. Nepolo Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Videos
Challenges to Widespread PrEP in Europe: Social Aspects - Michael Meulbroek
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Challenges to Widespread PrEP in Europe: Clinical Aspects - Milosz Parczewski, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Overview of the current situation regarding PrEP and resistance - Daniel Kuritzkes, MD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
ViiV Pipeline - Michael Aboud, MBChB
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
HIV Pipeline - Kirsten White, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Hepatitis C Resistance: Pro Standpoint - Francesca Ceccherini - Silberstein, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Hepatitis C Resistance: Con Standpoint - JM Pawlotsky, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Treatment of Hepatitis B for HIV Clinicians - Anna Maria Geretti, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Management of the COVID 19 Pandemic in Europe: Diagnostics - Ravindra Gupta, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Resistance to Long-Acting Antivirals - Anne-Geneviève Marcelin, PharmD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Clinical Case - Romain Palich, MD
Presented at:
European Meeting on HIV & Hepatitis 2020